liraglutide semaglutide tirzepatide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and # liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Tirzepatide vs liraglutide: complete comparison

GLP-1 agonists are powerful weight loss tools, but certain medications can reduce their effectiveness or cause harmful interactions

A GLP-1/GIP/Glucagon receptor agonist, Retatrutide and an experimental ERR agonist SLU-PP-332 coupled with mitochondrial activity and endurance performance is one of such combinations.

It is administered via a weekly injection and is effective when combined with diet and exercise.

Learn how GLP-1 medications and HRT (hormone replacement therapy) work together to reduce weight gain, insulin resistance, and diabetes risk in menopause.

A new weight-loss drug could offer hope to many patients even if the researchers fumbled a new psychological study